Biotron Limited

11 articles about Biotron Limited

• Nanomix Announces Distribution Agreement for the eLab System with Biotron Ltd. in Israel

  7/21/2022

  Nanomix Corporation today announced that it has entered into a distribution agreement with Biotron Ltd. (“Biotron”), an Israeli medical diagnostics distributor. 

• Biotron Drug Effective Against COVID-19 In Animals

  11/25/2021

  The Directors of Biotron Limited are pleased to announce that the Company's lead clinical asset, BIT225, has demonstrated substantial and clinically meaningful efficacy against SARS-CoV-2 in a series of animal and cell-based studies performed at The SCRIPPS Research Institute, La Jolla, CA, USA.

• UPDATE ON PROGRESS OF BIT225 PHASE 2 HIV-1 CLINICAL TRIAL

  8/7/2018

  The Directors of Biotron Limited (ASX: BIT) are pleased to provide an update on the progress of the company’s proof-of-concept HIV-1 clinical trial.

• Biotron Limited Release: Update On Progress Of Bit225 Phase 2 Hiv-1 Clinical Trial

  6/15/2017

• Biotron Limited Release: Commencement Of BIT225 Phase ll HIV-1 Clinical Trial

  2/13/2017

• Biotron Limited Phase 2 Hepatitis C Trial Success

  3/17/2016

• Biotron Limited Release: Potential Eradication Of HIV Resevoirs Data Published

  12/3/2015

• Biotron Limited Release: BIT225 Trial Results Show Effective Cure Of Hepatitis C

  10/10/2014

• Biotron Limited BIT225 Reverses HIV-Induced Impairment Of The Immune System

  7/23/2014

• Biotron Limited Shares Soared on October 10, 2011 on Hepatitis C Phase 2a Positive Results

  10/11/2011

• Biotron Limited Landmark HIV Trial Underway

  9/29/2011